Ogihara Toshio, Rakugi Hiromi
Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Drugs Aging. 2005;22(4):297-314. doi: 10.2165/00002512-200522040-00003.
Elderly individuals with hypertension show specific characteristics as a result of advancing arteriosclerosis, a high frequency of isolated systolic hypertension, increased pulse pressure and orthostatic hypotension. The necessity to treat hypertension in the elderly, including isolated systolic hypertension, has been demonstrated in many large-scale intervention trials. Young-old (65-74 years of age) hypertensive patients should be treated the same as nonelderly hypertensive patients. In old-old (75-84 years of age) patients with mild hypertension (140-159/90-99 mm Hg), the recommended target blood pressure (BP) is <140/90 mm Hg. In old-old (75-84 years of age) and oldest-old (> or =85 years of age) patients with systolic BP > or =160 mm Hg, cautious treatment is required. An intermediate target BP of <150 mm Hg is appropriate, followed by a final target BP of <140 mm Hg, if tolerated. Nonmedical therapy, such as salt restriction, exercise and weight reduction, is useful in the elderly. However, individualised management of nonmedical therapy is necessary to avoid deterioration of quality of life resulting from strict management of the patient's lifestyle. Diuretics, calcium channel antagonists, ACE inhibitors and angiotensin II type 1 receptor antagonists have been established as first-line antihypertensive drugs in the elderly. Use of combination therapy helps to achieve target BPs. The starting dose of each drug should be half the usual dose for nonelderly patients, and may be increased at intervals of >4 weeks, with achievement of the target BP in 3-6 months or longer. In hypertensive patients with co-morbid diseases, the target BP should be determined individually and antihypertensive drugs selected bearing in mind the patient's clinical circumstances. Avoiding hypoperfusion of target organs is very important in elderly hypertensive patients. When treating hypertension in elderly patients, the approach should be to identify individual pathophysiological characteristics and lower the BP cautiously and slowly.
老年高血压患者由于动脉硬化进展、单纯收缩期高血压发生率高、脉压增大和体位性低血压而表现出特定特征。许多大规模干预试验已证明治疗老年高血压患者(包括单纯收缩期高血压)的必要性。年轻老年人(65 - 74岁)高血压患者的治疗应与非老年高血压患者相同。在年龄较大的老年人(75 - 84岁)轻度高血压患者(140 - 159/90 - 99 mmHg)中,推荐的目标血压(BP)<140/90 mmHg。在年龄较大的老年人(75 - 84岁)和高龄老年人(≥85岁)收缩压≥160 mmHg的患者中,需要谨慎治疗。如果耐受,合适的中间目标血压为<150 mmHg,最终目标血压为<140 mmHg。非药物治疗,如限盐、运动和减重,对老年人有用。然而,非药物治疗的个体化管理对于避免因严格管理患者生活方式而导致生活质量下降是必要的。利尿剂、钙通道拮抗剂、ACE抑制剂和血管紧张素II 1型受体拮抗剂已被确立为老年人的一线抗高血压药物。联合治疗有助于实现目标血压。每种药物的起始剂量应为非老年患者常用剂量的一半,可每隔>4周增加剂量,在3 - 6个月或更长时间内达到目标血压。对于合并其他疾病的高血压患者,应根据患者的临床情况个体化确定目标血压并选择抗高血压药物。在老年高血压患者中避免靶器官灌注不足非常重要。治疗老年患者高血压时,应识别个体病理生理特征,谨慎、缓慢地降低血压。